A detailed history of California State Teachers Retirement System transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, California State Teachers Retirement System holds 70,431 shares of CRSP stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,431
Previous 72,903 3.39%
Holding current value
$3.3 Million
Previous $3.94 Million 15.95%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$44.62 - $62.75 $110,300 - $155,118
-2,472 Reduced 3.39%
70,431 $3.31 Million
Q2 2024

Aug 14, 2024

BUY
$51.17 - $68.18 $255,952 - $341,036
5,002 Added 7.37%
72,903 $3.94 Million
Q1 2024

May 15, 2024

BUY
$60.67 - $89.12 $43,075 - $63,275
710 Added 1.06%
67,901 $4.63 Million
Q4 2023

Feb 13, 2024

BUY
$38.62 - $72.18 $34,101 - $63,734
883 Added 1.33%
67,191 $4.21 Million
Q3 2023

Nov 14, 2023

BUY
$45.39 - $59.0 $25,599 - $33,276
564 Added 0.86%
66,308 $3.01 Million
Q2 2023

Aug 21, 2023

BUY
$43.47 - $67.77 $17,518 - $27,311
403 Added 0.62%
65,744 $3.69 Million
Q1 2023

May 09, 2023

BUY
$41.0 - $56.12 $35,260 - $48,263
860 Added 1.33%
65,341 $2.96 Million
Q4 2022

Feb 14, 2023

BUY
$39.19 - $65.67 $45,813 - $76,768
1,169 Added 1.85%
64,481 $2.62 Million
Q3 2022

Nov 18, 2022

BUY
$61.1 - $83.78 $34,582 - $47,419
566 Added 0.9%
63,312 $4.14 Million
Q2 2022

Aug 15, 2022

BUY
$43.23 - $73.83 $462,474 - $789,833
10,698 Added 20.55%
62,746 $3.81 Million
Q1 2022

May 16, 2022

BUY
$53.19 - $79.24 $24,573 - $36,608
462 Added 0.9%
52,048 $3.27 Million
Q4 2021

Feb 15, 2022

BUY
$70.09 - $111.29 $137,796 - $218,796
1,966 Added 3.96%
51,586 $3.91 Million
Q3 2021

Nov 15, 2021

BUY
$110.2 - $156.64 $5.47 Million - $7.77 Million
49,620 New
49,620 $5.55 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.65B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.